TABLE 3.
Subgroup | No of trials | Pessary | No pessary | Relative risk (95% CI) | I2, % | Interaction P value |
---|---|---|---|---|---|---|
Concomitant use of vaginal progesterone | 0.70 | |||||
No | 4160–162,164 | 31/521 (6.0%) | 67/518 (12.9%) | 0.70 (0.23–2.14) | 78 | |
Yes | 3162–164 | 62/408 (15.2%) | 67/417 (16.1%) | 0.91 (0.47–1.76) | 67 | |
Obstetric history | 0.24 | |||||
No previous preterm birth | 3162,164,165 | 78/605 (12.9%) | 72/591 (12.2%) | 0.97 (0.54–1.76) | 71 | |
≥1 previous preterm birth | 1162 | 7/70 (10.0%) | 16/84 (19.0%) | 0.53 (0.23–1.20) | NA | |
Cervical length | 0.68 | |||||
≤10 mm | 2162,164 | 28/111 (25.2%) | 25/83 (30.1%) | 0.58 (0.10–3.23) | 85 | |
11–25 mm | 2162,164 | 38/504 (7.5%) | 48/534 (9.0%) | 0.84 (0.56–1.27) | 0 |
Data are n/N.
CI, confidence interval; NA, not applicable.